Talking Research - Walter Scott

Talking Research Q3 2023 update
For investment professionals only In Walter Scott's latest quarterly podcast, Investment Manager Paul Loudon considers current goings-on in China and why, in his view, the picture there is not all doom and gloom. He also shares insights from recent debates and the team’s latest travels before fellow Investment Manager Lindsay Scott joins him to talk about the ground-breaking, hugely topical and often controversial obesity drugs that have been developed by Novo Nordisk and Eli Lilly. Our podcast episodes are intended solely for institutional investors, investment professionals, investment consultants and financial intermediaries only and should not be construed as investment advice or a recommendation. Any stock examples discussed are given in the context of the theme being explored, and the views expressed are those of the presenters at the time of the recording.
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
